On Tuesday, a Pfizer board member said that the U.S. government been offered 100 million more doses that could be delivered in the spring, but declined. The board member, Scott Gottlieb, said the company made multiple offers, as recently as about a month ago when the company said it had shown the shot was highly effective. But the Trump administration declined.



Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *